Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®).
Heath MD, Mohsen MO, de Kam PJ, Carreno Velazquez TL, Hewings SJ, Kramer MF, Kündig TM, Bachmann MF, Skinner MA. Heath MD, et al. Among authors: kramer mf. Front Immunol. 2020 Nov 24;11:594911. doi: 10.3389/fimmu.2020.594911. eCollection 2020. Front Immunol. 2020. PMID: 33324411 Free PMC article. Review.
Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.
Leuthard DS, Duda A, Freiberger SN, Weiss S, Dommann I, Fenini G, Contassot E, Kramer MF, Skinner MA, Kündig TM, Heath MD, Johansen P. Leuthard DS, et al. Among authors: kramer mf. J Immunol. 2018 May 1;200(9):3151-3159. doi: 10.4049/jimmunol.1800035. Epub 2018 Mar 28. J Immunol. 2018. PMID: 29592962 Free PMC article.
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.
Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF. Mohsen MO, et al. Among authors: kramer mf. J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z. J Immunother Cancer. 2019. PMID: 31027511 Free PMC article.
Clinical use of adjuvants in allergen-immunotherapy.
Klimek L, Schmidt-Weber CB, Kramer MF, Skinner MA, Heath MD. Klimek L, et al. Among authors: kramer mf. Expert Rev Clin Immunol. 2017 Jun;13(6):599-610. doi: 10.1080/1744666X.2017.1292133. Epub 2017 Feb 23. Expert Rev Clin Immunol. 2017. PMID: 28162007 Review.
Major Allergen Content in Allergen Immunotherapy Products: The Limited Value of Numbers.
Becker S, Fassio F, Muñoz-Cano R, Klimek L, Vidal C, Heath MD, Kündig TM, Vogelberg C, Toran C, Jensen-Jarolim E, Heffler E, Tomazic PV, Feindor M, Hewings S, Carreno T, Morales M, Mösges R, Skinner MA, Graessel A, Hernandez D, Kramer MF. Becker S, et al. Among authors: kramer mf. J Investig Allergol Clin Immunol. 2022 Oct 11;32(5):345-356. doi: 10.18176/jiaci.0822. Epub 2022 May 6. J Investig Allergol Clin Immunol. 2022. PMID: 35522054 Free article. Review.
Immunological effects of adjuvanted low-dose allergoid allergen-specific immunotherapy in experimental murine house dust mite allergy.
Heldner A, Alessandrini F, Russkamp D, Heine S, Schnautz B, Chaker A, Mwange J, Carreno Velazquez TL, Heath MD, Skinner MA, Kramer MF, Zissler UM, Schmidt-Weber CB, Blank S. Heldner A, et al. Among authors: kramer mf. Allergy. 2022 Mar;77(3):907-919. doi: 10.1111/all.15012. Epub 2021 Jul 26. Allergy. 2022. PMID: 34287971
Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
De Kam PJ, Kramer MF, Shamji MH, Oluwayi K, Heath MD, Jensen-Jarolim E, Berger MH, Berger UE, Graessel A, Sellwood F, Zielen S, Vogelberg C, Zieglmayer P, Mösges R, Klimek L, DuBuske LM, Shreffler WG, Bernstein JA, Kündig TM, Skinner MA. De Kam PJ, et al. Among authors: kramer mf. World Allergy Organ J. 2021 Sep 28;14(9):100578. doi: 10.1016/j.waojou.2021.100578. eCollection 2021 Sep. World Allergy Organ J. 2021. PMID: 34659627 Free PMC article. Review.
182 results